Correlation Between Inhibrx and Edgewise Therapeutics
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Edgewise Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Edgewise Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Edgewise Therapeutics, you can compare the effects of market volatilities on Inhibrx and Edgewise Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Edgewise Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Edgewise Therapeutics.
Diversification Opportunities for Inhibrx and Edgewise Therapeutics
0.02 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Inhibrx and Edgewise is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Edgewise Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edgewise Therapeutics and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Edgewise Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edgewise Therapeutics has no effect on the direction of Inhibrx i.e., Inhibrx and Edgewise Therapeutics go up and down completely randomly.
Pair Corralation between Inhibrx and Edgewise Therapeutics
Given the investment horizon of 90 days Inhibrx is expected to under-perform the Edgewise Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Inhibrx is 1.75 times less risky than Edgewise Therapeutics. The stock trades about -0.01 of its potential returns per unit of risk. The Edgewise Therapeutics is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 1,744 in Edgewise Therapeutics on September 2, 2024 and sell it today you would earn a total of 1,556 from holding Edgewise Therapeutics or generate 89.22% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inhibrx vs. Edgewise Therapeutics
Performance |
| Timeline |
| Inhibrx |
| Edgewise Therapeutics |
Inhibrx and Edgewise Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibrx and Edgewise Therapeutics
The main advantage of trading using opposite Inhibrx and Edgewise Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Edgewise Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edgewise Therapeutics will offset losses from the drop in Edgewise Therapeutics' long position.| Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
| Edgewise Therapeutics vs. Tff Pharmaceuticals | Edgewise Therapeutics vs. Eliem Therapeutics | Edgewise Therapeutics vs. Inhibrx | Edgewise Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |